Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia
Clinical trial NCT03228303 · UNKNOWN
Trial details
- NCT number
- NCT03228303
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2020-07-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.